ArticleAmerican journal of nephrology2020
Availability and Affordability of Kidney Health Laboratory Tests around the Globe.
Article in American journal of nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 37 citations in OpenAlex.
- Are your kidneys okay? Detect early to protect kidney health.Kidney research and clinical practice · 2026Article
- From resolution to reality: advancing point-of-care diagnostics for kidney disease in low-resource settings.Nature reviews. Nephrology · 2026Article
- Are your kidneys ok? Detect early to protect kidney health.Renal failure · 2025Article
- Are your kidneys ok? Detect early to protect kidney health.Clinical and experimental nephrology · 2025Article
- Are Your Kidneys Ok? Detect Early to Protect Kidney Health.American journal of hypertension · 2025Review
- The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese non-diabetic patients.Clinical and experimental nephrology · 2025Article
- Are Your Kidneys Ok? Detect Early to Protect Kidney Health.Kidney international reports · 2025Article
- Are Your Kidneys Ok? Detect Early to Protect Kidney Health.Canadian journal of kidney health and disease · 2025Article
- The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese patients with type 2 diabetes.Journal of diabetes investigation · 2025Article
- Utility of a novel point-of-care test for albuminuria in communities at high risk for chronic kidney disease in Thailand.BMJ public health · 2025Article
- Geo-mapping of government healthcare facilities providing diagnostic laboratory services in Delhi, India: a pilot study.BMJ public health · 2025Article
- Structures, Organization, and Delivery of Kidney Care to Children Living in Low-Resource Settings.Kidney international reports · 2024Article
- Chronic kidney disease and the global public health agenda: an international consensus.Nature reviews. Nephrology · 2024Review
- What should European nephrology do with the new CKD-EPI equation?Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023Article
- Longitudinal Estimated Glomerular Filtration Rate Trajectories in Children with Type 1 Diabetes.Pediatric diabetes · 2023Article
- Are Your kidneys ok? Detect early to protect kidney health.Jornal brasileiro de nefrologiaArticle
- Are Your Kidneys Ok? Detect Early to Protect Kidney Health.Indian journal of nephrologyArticle
- Are Your Kidneys OK? Detect Early to Protect Kidney Health.Kidney diseases (Basel, Switzerland)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 6 institutions in 5 countries.
Funding
Abstract
backgroundKidney disease is a major global public health problem, and laboratory testing of kidney health measures is essential for diagnosis and monitoring. The availability and affordability of kidney health laboratory tests across countries has not been systematically described.
methodsThe International Society of Nephrology (ISN), in partnership with leaders of a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, surveyed a representative subset of ISN-Global Kidney Health Atlas (ISN-GKHA) respondents from April to June 2020. We assessed the association between country gross national income (GNI) per capita and laboratory testing availability and affordability.
resultsOf 33 regional expert nephrologists invited, 24 (73%) responded, representing all 10 ISN regions around the world. Availability of kidney health laboratory tests was as follows: serum Cr (100%), serum cystatin C (67%), urine albumin (96%), urine Cr (100%), and dipstick urinalysis (100%). Median (IQR) reimbursement values in international dollars were as follows: serum Cr Int$ 6.61 (3.42-8.84), serum cystatin C Int$ 31.51 (17.36-46.25), urine albumin Int$ 10.22 (5.90-15.42), urine Cr Int$ 7.50 (1.66-8.84), and dipstick urinalysis Int$ 6.26 (2.56-8.40). Reimbursement values did not differ significantly by World Bank income group or by GNI per capita.
conclusionThere was widespread availability of kidney health laboratory tests and substantial variation in reimbursement values. To achieve meaningful progress across nations in mitigating the growth of kidney disease, access to affordable diagnostic technology is essential. Our results are highly relevant to policymakers and researchers as countries increasingly consider national strategies for kidney disease detection and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.